Discover More with Multiple Methods | A Case Study on Pancreatic Cancer Research

24 January 2019

Over the past 40 years, the survival rates for many types of cancer have seen great improvements. However, the survival rate for pancreatic cancer has remained relatively unchanged. Learn how researchers, by applying multiple genomic methods, were able to identify four subtypes of the disease as well as determine mutational mechanisms and genomic events important in disease progression—breakthroughs that wouldn’t have been possible with a single method. Learn more at http://discovery.illumina.com/ A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on